Korean J Med.  2004 May;66(5):532-537.

A case of hepatic candidiasis: Successful treatment with fluconazole

Affiliations
  • 1Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea. jskim@damc.or.kr
  • 2Medical Research Center for Cancer Molecular Therapy, Dong-A University College of Medicine, Busan, Korea.

Abstract

The frequency of invasive fungal infections has increased during the period of chemotherapy. Fungal infections are an increasing cause of morbidity and mortality in patients with hematological malignancies. The most common organism are Candida albicans. This report describes our experience in a 28-year-old woman who developed symptoms of hepatic candidiasis which were confirmed with liver biopsy after remission induction chemotherapy for acute myeloid leukemia. In our case, the patient did not improve clinically despite administration of 610 mg amphotericin B. Severe leukocytosis, increasing alkaline phosphatase and clinical deterioration developed rapidly, and then we switched to fluconazole, taking into consideration successful fluconazole treatment of patients with chronic disseminated candidiasis and acute hepatic candidiasis. She remains in clinically and radiological improving at the time of this report.

Keyword

Amphotericin B; Hepatic candidiasis; Fluconazole

MeSH Terms

Adult
Alkaline Phosphatase
Amphotericin B
Biopsy
Candida albicans
Candidiasis*
Drug Therapy
Female
Fluconazole*
Hematologic Neoplasms
Humans
Leukemia, Myeloid, Acute
Leukocytosis
Liver
Mortality
Remission Induction
Alkaline Phosphatase
Amphotericin B
Fluconazole
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr